Emami (531162) Aktievy
Emami Limited tillverkar och marknadsför produkter för personlig hygien och sjukvård i Indien och internationellt. Mer information
| Snöflinga Score | |
|---|---|
| Värdering | 4/6 |
| Framtida tillväxt | 2/6 |
| Tidigare resultat | 3/6 |
| Finansiell hälsa | 6/6 |
| Utdelningar | 6/6 |
Belöningar
Riskanalys
Inga risker upptäckta för 531162 från våra riskkontroller.
531162 Community Fair Values
Create NarrativeSee what 8 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Emami Limited Konkurrenter
Prishistorik och prestanda
| Historiska aktiekurser | |
|---|---|
| Aktuell aktiekurs | ₹392.35 |
| 52 veckors högsta | ₹634.65 |
| 52 veckors lägsta | ₹376.05 |
| Beta | 0.16 |
| 1 månads förändring | -6.52% |
| 3 månaders förändring | -13.24% |
| 1 års förändring | -36.03% |
| 3 års förändring | -20.25% |
| 5 års förändring | -29.98% |
| Förändring sedan börsintroduktionen | 16,655.18% |
Senaste nyheter och uppdateringar
531162: Upcoming May Results Will Support Bullish Long-Term Outlook
Analysts have trimmed their fair value estimate for Emami to ₹671 from about ₹745, citing updated expectations around revenue growth, profit margins and a lower projected future P/E multiple. What’s in the News for Emami Emami has scheduled a board meeting on May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
531162: May Board Meeting And Leadership Review Will Support Bullish Outlook
Analysts have trimmed their price target on Emami to ₹545 from about ₹637, citing refreshed assumptions around slightly higher discount rates, more moderate revenue growth, softer profit margins, and a lower future P/E multiple. What’s in the News for Emami Emami has scheduled a Board meeting on May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.Recent updates
531162: Upcoming May Results Will Support Bullish Long-Term Outlook
Analysts have trimmed their fair value estimate for Emami to ₹671 from about ₹745, citing updated expectations around revenue growth, profit margins and a lower projected future P/E multiple. What’s in the News for Emami Emami has scheduled a board meeting on May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.531162: May Board Meeting And Leadership Review Will Support Bullish Outlook
Analysts have trimmed their price target on Emami to ₹545 from about ₹637, citing refreshed assumptions around slightly higher discount rates, more moderate revenue growth, softer profit margins, and a lower future P/E multiple. What’s in the News for Emami Emami has scheduled a Board meeting on May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
531162: Trimmed Fair Value And Rich Future P/E Will Shape Measured Outlook
Analysts have trimmed their price target on Emami from ₹425.00 to ₹415.00, reflecting updates to their models that now factor in different assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.531162: Upcoming May Results And Board Decisions Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami from ₹800 to about ₹745, citing updated assumptions that include slightly higher revenue growth expectations, along with a lower projected profit margin and a reduced future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).531162: Upcoming Results And Higher Board Meeting Focus Will Support Bullish Outlook
Analysts have raised their price target on Emami from ₹775.37 to ₹800.00, reflecting updated assumptions around discount rates, revenue growth, profit margins, and future P/E multiples. What's in the News Emami has scheduled a board meeting for May 21, 2026.531162: Interim Dividend Will Be Insufficient To Offset Rich Future P/E
Analysts have cut their price target on Emami from about ₹453 to ₹425, reflecting updated assumptions for slightly higher revenue growth, a marginally higher discount rate, and a lower future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).531162: Interim Dividend And Revised Assumptions Will Support A Balanced Outlook
Analysts have trimmed their price target on Emami from ₹510 to about ₹453, pointing to updated assumptions around a lower future P/E multiple, an adjusted discount rate, and revised expectations for revenue growth and profit margins. What's in the News The board of directors declared a 2nd interim dividend of ₹6 per equity share of face value ₹1 each, described as 600% on 436,500,000 equity shares for the financial year 2025-26 (Key Developments).531162: Second Interim Dividend Will Support Bullish Long Term Outlook
Analysts have trimmed their price target on Emami by about ₹31 to reflect updated assumptions around fair value, discount rate, revenue growth, profit margin, and future P/E expectations. What's in the News The board approved a second interim dividend of ₹6 per equity share of ₹1 each, equal to 600% on 436,500,000 equity shares for FY 2025-26, with the record date set for 10 February 2026 and payment scheduled on or before 6 March 2026 (Key Developments).531162: February Dividend And Board Review Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami to ₹637 from ₹651, citing slightly adjusted assumptions on discount rate, revenue growth, profit margin and future P/E that point to a marginally more conservative outlook on the stock's valuation. What's in the News A board meeting on 4 February 2026 to review unaudited standalone and consolidated financial results for the quarter ended 31 December 2025 and to consider a 2nd interim dividend for FY 2025-26 (company filing).531162: Interim Dividend And Stable Assumptions Will Support A Balanced Outlook
Analysts have maintained their fair value estimate for Emami at ₹510. They have made only minor adjustments to assumptions such as discount rate, revenue growth, profit margin and future P/E, which feed into the updated price target rationale.531162: Board Review And Interim Dividend Will Shape A Balanced Outlook
Analysts have trimmed their price target for Emami from ₹540.54 to ₹510.00, citing refreshed assumptions that include slight adjustments to revenue growth, profit margins and the future P/E multiple under a marginally lower discount rate. What's in the News Emami has scheduled a board meeting on Feb 04, 2026 to review unaudited standalone and consolidated financial results for the quarter ended 31 December, 2025 (Key Developments).531162: February Board Meeting And Dividend Decision Will Reinforce Bullish Outlook
Analysts have trimmed their price target for Emami slightly to ₹651 from about ₹653. The adjustment reflects small tweaks to their fair value, discount rate, revenue growth and profit margin assumptions, alongside a marginally lower expected future P/E multiple.531162: February Dividend Decision Will Support Bullish Long-Term View
Analysts have made only a minor adjustment to their price view on Emami, with the updated fair value at ₹653.25. A slightly lower discount rate, along with revised assumptions for revenue growth, profit margin, and future P/E, serve to fine tune rather than overhaul the prior framework.531162: Upcoming Dividend Decision Will Support Bullish Long Term Outlook
Analysts have trimmed their price target on Emami from ₹883 to ₹807. This reflects slightly lower margin and valuation expectations that more than offset modestly stronger projected revenue growth and a reduced discount rate.531162: Interim Dividend Decision At November Meeting Will Support Bullish Outlook
Analysts have nudged their price target on Emami slightly higher to align with a fair value of ₹653.25. This reflects marginally lower perceived risk and a steady outlook on growth, margins, and future valuation multiples.531162: Board Will Consider Interim Dividend At November 10 Results Meeting
Analysts have revised their price target for Emami down from ₹697.96 to ₹653.25. They cite updated assessments of the company's growth prospects and valuation metrics as reasons for the change.531162: Board To Weigh Interim Dividend At November 10 Meeting
Analysts have slightly revised their price target for Emami downward from ₹706.24 to ₹697.96. This change reflects minor adjustments in growth and profitability expectations.
Relaunching Fair And Handsome And Capitalizing On Dermicool Innovations Will Propel Earnings Growth
Strategic relaunches and product innovations aim to boost revenue, particularly in Fair and Handsome, Kesh King, Dermicool, and BoroPlus Soft segments.Aktieägarnas avkastning
| 531162 | IN Personal Products | IN Marknad | |
|---|---|---|---|
| 7D | -3.6% | -1.2% | 2.2% |
| 1Y | -36.0% | -13.3% | 3.8% |
Avkastning vs industri: 531162 presterade sämre än Indian Personal Products branschen som gav -13.3 % under det senaste året.
Avkastning vs Marknaden: 531162 presterade sämre än Indian marknaden som gav 3.8 % under det senaste året.
Prisvolatilitet
| 531162 volatility | |
|---|---|
| 531162 Average Weekly Movement | 3.6% |
| Personal Products Industry Average Movement | 4.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 3.7% |
Stabil aktiekurs: 531162 har inte haft någon betydande prisvolatilitet under de senaste 3 månaderna jämfört med marknaden för Indian.
Volatilitet över tid: 531162 s veckovolatilitet ( 4% ) har varit stabil under det senaste året.
Om företaget
| Grundad | Anställda | VD OCH KONCERNCHEF | Webbplats |
|---|---|---|---|
| 1974 | 3,097 | Harsha Agarwal | www.emamiltd.in |
Emami Limited tillverkar och marknadsför produkter för personlig hygien och hälsovård i Indien och internationellt. Företaget tillhandahåller ayurvedisk antiseptisk kräm, prickly heat-pulver, doodh kesar bodylotion, aloe neem-lotion, vasocare växtbaserad vaselin, kokosolja, aloe vera-gel och hygienprodukter under varumärket Boroplus; cool oil, extra thanda, gold ayurvedic oil, therapy ayurvedic body massage and stress relief oil, maxx cool talk och cool talk under varumärket Navratna; och balm, balm ultra-power, quick relief roll-on, ortho vedic oil, salva, relief gel och spray, hälsovårdsprodukter, pancharishta, nityam och kesari jivan under varumärket Zandu. Företaget erbjuder också radiance cream och instant radiance face wash för män under varumärket Fair and Handsome; hårvårdsprodukter och schampo under varumärket Kesh King; balsam under varumärket Mentho Plus; prickly heat powder under varumärket Dermicool; hårolja, schampo och balsam under varumärket Emami 7 Oils in One; deodoranter under varumärket HE; hårfärger under varumärket Emami Diamond Shine, talk under varumärket Emami Golden Beauty, örtkräm för skönhet under varumärket Emami Naturally Fair, tandkräm under varumärket Ayucare, hårfärger och oljor under varumärket Emami Gold samt fuktkrämer, lotion, mjuka krämer, glycerinkrämer och -oljor, vaselin, babyschampo och andra hudprodukter under varumärket Cream21.
Emami Limited Sammanfattning av grunderna
| 531162 grundläggande statistik | |
|---|---|
| Börsvärde | ₹171.26b |
| Vinst(TTM) | ₹7.75b |
| Intäkter(TTM) | ₹37.80b |
Är 531162 övervärderat?
Se Verkligt värde och värderingsanalysResultat & intäkter
| 531162 resultaträkning (TTM) | |
|---|---|
| Intäkter | ₹37.80b |
| Kostnad för intäkter | ₹11.77b |
| Bruttovinst | ₹26.03b |
| Övriga kostnader | ₹18.27b |
| Intäkter | ₹7.75b |
Senast redovisade vinst
Mar 31, 2026
Nästa vinstdatum
Nov 13, 2026
| Vinst per aktie (EPS) | 17.76 |
| Bruttomarginal | 68.86% |
| Nettovinstmarginal | 20.51% |
| Skuld/egenkapitalförhållande | 4.2% |
Hur har 531162 utvecklats på lång sikt?
Se historisk utveckling och jämförelseUtdelningar
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/08/04 21:19 |
| Aktiekurs vid dagens slut | 2026/08/04 00:00 |
| Intäkter | 2026/03/31 |
| Årlig intjäning | 2026/03/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som används för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och handledningar på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Emami Limited bevakas av 47 analytiker. 19 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Parin Tanna | 360 ONE Capital Market Private Limited |
| Ajay Thakur | Anand Rathi Shares and Stock Brokers Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |